Lupin inks licensing pact with Axantia for Pegfilgrastim

The Mumbai-based drug firm has entered into a license, supply and technology sharing agreement with Axantia Holding, a leading pharmaceutical company in the Middle East region, Lupin said in a statement.

from Moneycontrol Business News https://ift.tt/gf4DFTXMR